IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: contrarian who wrote (1315)	10/12/1997 10:27:00 PM
From: Richard Cohen	of 1762

Thanks alot for the info. I'm a family physician and these new advances fascinate me. Another explosive biotech stock to watch is BTIM. I have been on board with them for the past two years. They have a liscensing agreement with Abott to produce a plasma extender called Hextend. Hextend recently completed Phase 3 trials without a hitch and will be approved by the FDA shortly. Hextend is unlike any existinfg product because it causes no coagulation problems and can be used for low temperature surgery for extended organ transplantation and trauma. The stock has had quite a runup over the last month but that is only the beginning. They announced a 3-1 split which will allow instituional buyers to get involved.(There is only a 3 mill float with insiders owning 1.5 mill) There is a potential 3-5 billion$ plasma extender market in the U.S. alone. This looks like another "attic stock" Again thanks for the info and LOL. Rich

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next